Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Undiscovered Gems Three Promising Stocks For January 2025

In This Article:

As global markets navigate through a period of uncertainty marked by inflation concerns and political shifts, small-cap stocks have faced notable challenges, with the Russell 2000 Index recently dipping into correction territory. Amidst this backdrop, discerning investors may find opportunities in lesser-known stocks that demonstrate strong fundamentals and resilience to market volatility.

Top 10 Undiscovered Gems With Strong Fundamentals

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

Darya-Varia Laboratoria

NA

1.44%

-11.65%

★★★★★★

Zambia Sugar

1.04%

20.60%

44.34%

★★★★★★

AB Vilkyskiu pienine

35.79%

17.20%

49.04%

★★★★★★

ManpowerGroup Greater China

NA

14.56%

1.58%

★★★★★★

Prima Andalan Mandiri

0.94%

20.24%

15.28%

★★★★★★

All E Technologies

NA

27.05%

31.58%

★★★★★★

China Leon Inspection Holding

8.55%

21.36%

22.77%

★★★★★★

HOMAG Group

NA

-31.14%

23.43%

★★★★★☆

BBGI Global Infrastructure

0.02%

3.08%

6.85%

★★★★★☆

Arsan Tekstil Ticaret ve Sanayi Anonim Sirketi

0.75%

19.36%

52.36%

★★★★☆☆

Click here to see the full list of 4568 stocks from our Undiscovered Gems With Strong Fundamentals screener.

Here we highlight a subset of our preferred stocks from the screener.

MicroPort NeuroScientific

Simply Wall St Value Rating: ★★★★★★

Overview: MicroPort NeuroScientific Corporation focuses on the research, development, production, and sale of neuro-interventional medical devices both in China and internationally, with a market cap of approximately HK$4.87 billion.

Operations: MicroPort NeuroScientific generates revenue primarily from the sale of surgical and medical equipment, totaling CN¥774.66 million.

MicroPort NeuroScientific, a nimble player in the medical equipment sector, has showcased impressive growth with earnings surging 67% over the past year, outpacing industry averages. The company is trading at 57.6% below its estimated fair value, indicating potential undervaluation. With no debt on its books for five years and positive free cash flow of RMB 162 million as of January 2025, financial stability seems assured. Recent guidance projects net profit between RMB 236 million and RMB 270 million for 2024, marking a significant increase driven by expanded hospital coverage and overseas revenue growth.

SEHK:2172 Earnings and Revenue Growth as at Jan 2025
SEHK:2172 Earnings and Revenue Growth as at Jan 2025

Xinhuanet

Simply Wall St Value Rating: ★★★★★★

Overview: Xinhuanet Co., Ltd. operates a news information service portal in China with a market cap of CN¥11.29 billion.